Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Am J Obstet Gynecol. 2019 Nov 15;222(5):476.e1–476.e11. doi: 10.1016/j.ajog.2019.11.1251

Table 2.

Associations between analgesic medication use at three specific time points of the menstrual cycle and fecundability in the Time to Conceive cohort, 2008–2016

Time windows N of cyclesa N of conceptions Medications Minimally adjusted FR b (95% CI) Fully adjusted FRc (95% CI)
Pre-ovulatory 146 35 Acetaminophen 1.08 (0.77, 1.51) 1.02 (0.73, 1.44)
26 6 Aspirin 1.15 (0.57, 2.32) 1.05 (0.53, 2.09)
145 34 NSAID 1.04 (0.74, 1.46) 1.03 (0.73, 1.46)
1773 370 None 1 1
Peri-ovulatory 148 35 Acetaminophen 1.05 (0.74, 1.49) 0.97 (0.68, 1.37)
30 7 Aspirin 1.18 (0.61, 2.27) 1.20 (0.62, 2.29)
151 36 NSAID 1.08 (0.77, 1.52) 1.15 (0.82, 1.62)
1904 376 None 1 1
Implantation 180 49 Acetaminophen 1.25 (0.92, 1.69) 1.16 (0.85, 1.59)
25 9 Aspirin 1.97 (1.19, 3.27) 2.05 (1.23, 3.41)
146 37 NSAID 1.09 (0.77, 1.54) 1.11 (0.79, 1.57)
2032 377 None 1 1
Non- Menstrual Days 405 96 Acetaminophen 1.17 (0.93, 1.48) 1.14 (0.90, 1.44)
58 14 Aspirin 1.14 (0.72, 1.82) 1.11 (0.70, 1.75)
341 74 NSAID 0.93 (0.72, 1.21) 0.96 (0.74, 1.25)
1813 348 None 1 1
a

Categories are not mutually exclusive and do not sum to the total number of cycles

b

Minimally adjusted model contains all medication variables, age, race and education

c

Adjusted model is the minimal model plus frequency of intercourse in the fertile window, body mass index, caffeine intake, alcohol intake, and a history of migraines or uterine fibroids.